TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 243 filers reported holding TG THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,304,132 | +19.8% | 73,307 | +2.4% | 0.02% | +6.2% |
| Q1 2024 | $1,088,671 | -33.8% | 71,576 | -25.6% | 0.02% | -46.7% |
| Q4 2023 | $1,643,950 | +175.3% | 96,250 | +34.8% | 0.03% | +150.0% |
| Q3 2023 | $597,096 | -81.6% | 71,423 | -45.4% | 0.01% | -83.1% |
| Q2 2023 | $3,246,439 | +78.6% | 130,694 | +8.1% | 0.07% | +61.4% |
| Q1 2023 | $1,818,140 | +21.5% | 120,887 | -4.4% | 0.04% | +4.8% |
| Q4 2022 | $1,495,809 | +188.8% | 126,442 | +1075.5% | 0.04% | +82.6% |
| Q1 2021 | $518,000 | -70.5% | 10,756 | -68.1% | 0.02% | -60.3% |
| Q4 2020 | $1,754,000 | +94.5% | 33,716 | +0.0% | 0.06% | +100.0% |
| Q3 2020 | $902,000 | +3.4% | 33,700 | -24.8% | 0.03% | +11.5% |
| Q2 2020 | $872,000 | +1306.5% | 44,788 | +303.3% | 0.03% | +2500.0% |
| Q3 2019 | $62,000 | – | 11,105 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Jetstream Capital LLC | 200,000 | $7,758,000 | 5.97% |
| Lion Point Capital, LP | 609,128 | $23,628,000 | 4.08% |
| RA Capital Management | 3,342,743 | $129,665,000 | 2.08% |
| Ghost Tree Capital, LLC | 180,000 | $6,982,000 | 1.92% |
| Nicholas Investment Partners, LP | 660,964 | $25,639,000 | 1.61% |
| ARDSLEY ADVISORY PARTNERS LP | 350,000 | $13,577,000 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 414,949 | $16,096,000 | 1.30% |
| Spotlight Asset Group, Inc. | 75,000 | $2,909,000 | 1.12% |
| ACT CAPITAL MANAGEMENT, LLC | 55,000 | $2,134,000 | 1.10% |
| Pier Capital, LLC | 280,486 | $10,880,000 | 1.09% |